研究開発費、剰余金の配当、少数株主に係る包括利益他1件
- 【期間】
| 年度 | 研究開発費 | 剰余金の配当 | 少数株主に係る包括利益 | 投資有価証券評価損益（△は益） |
|---|
| 2008/03 | 31百万 | | - | | - | | - | |
| 2009/03 | - | | -6.6百万 | | - | | 16百万 | |
| 2010/03 | - | | - | | - | | 109百万 | +579% |
| 2010/09 | - | | - | | -0.53百万 | | - | |
| 2010/12 | - | | - | | -0.68百万 | 赤拡 | - | |
| 2011/03 | - | | - | | -0.93百万 | 赤拡 | - | |
| 2011/06 | - | | - | | 53,000 | 黒転 | - | |
| 2011/09 | - | | - | | 0.9百万 | 大幅増 | - | |
| 2011/12 | - | | - | | 2.6百万 | +192% | - | |
| 2012/03 | - | | -20百万 | 赤拡 | 3百万 | +12.9% | - | |
| 2012/06 | - | | - | | 1.9百万 | -35.3% | - | |
| 2012/09 | - | | - | | 2.6百万 | +35.5% | - | |
| 2012/12 | - | | - | | 4.6百万 | +76.9% | - | |
| 2013/03 | 24百万 | -23.2% | -146百万 | 赤拡 | 4.5百万 | -1.9% | - | |
| 2013/06 | - | | - | | 0.94百万 | -79% | - | |
| 2013/09 | - | | - | | 2.2百万 | +134.1% | - | |
| 2013/12 | - | | - | | 1.6百万 | -27.6% | - | |
| 2014/03 | 123百万 | +410.4% | - | | 4.8百万 | +199.6% | - | |
| 2014/06 | - | | - | | 0.23百万 | -95.2% | - | |
| 2014/09 | - | | - | | -0.75百万 | 赤転 | - | |
| 2014/12 | - | | - | | 0.55百万 | 黒転 | - | |
| 2015/03 | 89百万 | -27.2% | - | | 1.7百万 | +219.2% | - | |
| 2016/03 | 92百万 | +2.4% | - | | - | | - | |
| 2017/03 | 84百万 | -8.6% | - | | - | | - | |
| 2018/03 | 119百万 | +42.4% | - | | - | | - | |
| 2019/03 | 62百万 | -47.7% | - | | - | | - | |
| 2020/03 | 75百万 | +19.6% | - | | - | | - | |
| 2021/03 | 154百万 | +106.6% | - | | - | | - | |
| 2022/03 | 177百万 | +14.9% | - | | - | | - | |
| 2023/03 | 206百万 | +16.2% | - | | - | | - | |
| 2023/09 | - | | - | | - | | 1.1百万 | -99% |
